China Digest: China Resources Biopharmaceutical, ASTSiC, Qiyu snap funds

A researcher at Shanghai UniXell Biotechnology is observing the growth condition of pluripotent stem cells under a microscope. Source: Shanghai UniXell Biotechnology

Stephanie Li

13 January, 2023

AST Science and Technology China Resources Biopharmaceutical iQiyi Qiyu

Printed by Unregistered user on Tue, 15 Jul 2025 07:15:39 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

China Digest: China Resources Biopharmaceutical, ASTSiC, Qiyu snap funds

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China Digest: HK-based crypto firm Metalpha completes restructuring; e-bike maker TENWAYS bags $44m in Series A

China Digest: GeneAssist Therapeutics, Singular Medical, Witmem Technology snap funding

Read more from Greater China

China’s BAI Capital in the market raising second fund

China gives conditional nod to Synopsys-Ansys deal, removing last major hurdle

China Digest: China Resources Biopharmaceutical, ASTSiC, Qiyu snap funds

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China Digest: HK-based crypto firm Metalpha completes restructuring; e-bike maker TENWAYS bags $44m in Series A

China Digest: GeneAssist Therapeutics, Singular Medical, Witmem Technology snap funding

Read more from Greater China

China’s BAI Capital in the market raising second fund

China gives conditional nod to Synopsys-Ansys deal, removing last major hurdle

Register now to enjoy 3 free articles per month,
or log in to continue reading.